Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies

Clinical trial NCT05364021 · COMPLETED

Trial details

NCT number: NCT05364021
Sponsor: Longboard Pharmaceuticals
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Developmental and Epileptic Encephalopathy Dravet Syndrome Lennox Gastaut Syndrome

Start date: 2022-03-03
Primary completion: 2023-11-16
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.